SLC5A2 and congestive heart failure: This sequence of sections serves the ultimate aim of this review, which is to provide a balanced view on the value of SGLT2 inhibitors in chronic heart failure management by carefully analyzing the results of major clinical HFrEF and HFmrEF/HFpEF trials from the perspective of the validity of the primary composite endpoint applied in these investigations.